GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $52,101,000 | +37.3% | 240,205 | -26.9% | 0.18% | +28.4% |
| Q4 2020 | $37,941,000 | +20.2% | 328,750 | +1.4% | 0.14% | -10.2% |
| Q3 2020 | $31,576,000 | -18.8% | 324,361 | +2.4% | 0.16% | -32.9% |
| Q2 2020 | $38,891,000 | +51.3% | 316,903 | +7.9% | 0.23% | +16.4% |
| Q1 2020 | $25,713,000 | -22.1% | 293,623 | -7.0% | 0.20% | -2.0% |
| Q4 2019 | $33,024,000 | -51.9% | 315,845 | -47.1% | 0.20% | -57.1% |
| Q3 2019 | $68,719,000 | -30.6% | 597,404 | +4.0% | 0.48% | -29.4% |
| Q2 2019 | $98,984,000 | +4366.8% | 574,179 | +4268.7% | 0.68% | +4131.2% |
| Q1 2019 | $2,216,000 | +7.2% | 13,143 | -38.1% | 0.02% | -15.8% |
| Q4 2018 | $2,067,000 | -43.7% | 21,232 | -0.2% | 0.02% | -29.6% |
| Q3 2018 | $3,673,000 | +144.4% | 21,266 | +97.4% | 0.03% | +35.0% |
| Q2 2018 | $1,503,000 | -31.5% | 10,773 | -44.7% | 0.02% | -31.0% |
| Q1 2018 | $2,195,000 | -93.3% | 19,480 | -92.1% | 0.03% | -93.3% |
| Q4 2017 | $32,579,000 | +195.6% | 246,790 | +127.3% | 0.44% | +116.9% |
| Q3 2017 | $11,021,000 | +17.2% | 108,591 | +15.8% | 0.20% | +23.3% |
| Q2 2017 | $9,406,000 | +666.0% | 93,815 | +823.6% | 0.16% | +608.7% |
| Q1 2017 | $1,228,000 | +107.4% | 10,157 | +91.8% | 0.02% | +76.9% |
| Q4 2016 | $592,000 | – | 5,297 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|